Person: ŞEKER, MESUT
4 results
Search Results
Now showing 1 - 4 of 4
Publication Metadata only Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey(2014-01-01T00:00:00Z) OVEN USTAALIOGLU, Bala B.; Bilici, Ahmet; YILMAZ, Burçak E.; ALIUSTAOGLU, Mehmet; Seker, MESUT; VARDAR, Fugen; Gümüş, Mahmut; ŞEKER, MESUTPublication Open Access Scalp recurrence of cholangiocarcinoma after curative hepatectomy: A report of two cases(2017-12-01) Kunduz, ENVER; Serin, Kursat Rahmi; Şeker, MESUT; KUNDUZ, ENVER; ŞEKER, MESUTCholangiocarcinomas are the second most common primary liver malignancies. The lymphatics are the common route of metastatic spread for cholangiocarcinomas. The most frequent sites of metastasis are the liver, abdominal lymph nodes, peritoneum and lungs. Cutaneous metastasis of cholangiocarcinoma is rare, and most commonly occurs following percutaneous biliary drainage. Brain or skull metastases from this tumor are uncommon. However, these rare metastatic lesions may occasionally be the first disease manifestation, although scalp recurrence following curative treatment is uncommon. We herein present the cases of two patients with cholangiocarcinoma, who were evaluated as resectable based on the criteria for cholangiocarcinoma resectability, and developed scalp recurrence following curative hepatectomy. Therefore, although scalp recurrence is a rare occurrence following curative treatment for cholangiocarcinoma, metastases should be included in the differential diagnosis.Publication Open Access Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.(2019-01-01T00:00:00Z) Bilici, A; Selcukbiricik, F; Seker, MESUT; Oven, BB; Olmez, OF; Yildiz, O; Olmuscelik, O; Hamdard, J; Acikgoz, O; Cakir, A; Kapran, Y; Balik, E; Oncel, M; ŞEKER, MESUTBackground: Lymph node involvement is an important prognostic factor in patients with gastric cancer. The aim of this study was to determine the prognostic significance of metastatic lymph node ratio (MLNR) and compare it to the number of lymph node metastasis in pN3 gastric cancer. Methods: We retrospectively analyzed 207 patients with pN3 gastric cancer who had undergone radical gastrectomy. Prognostic factors and MLNR were evaluated by univariate and multivariate analysis. Results: An MLNR of 0.75 was found to be the best cut-off value to determine the prognosis of patients with pN3 gastric cancer (p = 0.001). The MLNR was significantly higher in patients with large-sized and undifferentiated tumors, vascular, lymphatic and perineural invasion, and total gastrectomy. In multivariate analysis, MLNR (p = 0.041), tumor differentiation (p = 0.046), and vascular invasion (p = 0.012) were found to be independent prognostic factors for disease-free survival, while both MLNR (p < 0.001) and pN stage (p = 0.002) were independent prognostic indicators, as was tumor size, for overall survival. There was significant difference with respect to the recurrence patterns between MLNR groups. Lymph node and peritoneal recurrences were significantly higher in patients with MLNR > 0.75 compared to the MLNR < 0.75 group (p < 0.05). However, recurrence patterns were similar between pN3a and pN3b. Conclusion: Our results showed that MLNR was a useful indicator to determine the prognosis and recurrence patterns of patients with radically resected gastric cancer. Moreover, MLNR is a beneficial and reliable technique for evaluating lymph node metastasis.Publication Metadata only Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.(2014-01-01T00:00:00Z) BILICI, A; INANC, M; ULAS, A; AKMAN, T; Seker, MESUT; BABACAN, NA; INAL, A; BAL, O; KORAL, L; SEVINC, A; TUFAN, G; ELKIRAN, ET; USTAALIOĞLU, BB; YAVUZSEN, T; ALKIS, N; OZKAN, M; GUMUS, M; ŞEKER, MESUT